2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.

Author:

Solnica Bogdan1ORCID,Sygitowicz Grażyna2ORCID,Sitkiewicz Dariusz2ORCID,Jóźwiak Jacek3ORCID,Kasperczyk Sławomir4ORCID,Broncel Marlena5ORCID,Wolska Anna6ORCID,Odrowąż-Sypniewska Grażyna7ORCID,Banach Maciej8ORCID

Affiliation:

1. Department of Clinical Biochemistry Jagiellonian University Medical College, Cracow, Poland

2. Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, Poland

3. Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Opole, Poland

4. Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland

5. Department of Internal Diseases and Clinical Pharmacology, Medical University of Lodz, Lodz, Poland

6. Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States

7. Collegium Medicum, Nicolaus Copernicus University in Toruń, Toruń, Poland, Poland

8. Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland

Abstract

Lipid disorders are the most common (even 70%) and worst monitored cardiovascular risk factor (only 1/4 of patients in Poland and CEE countries are on the LDL-C goal). In order to improve this the clear and easy to implement diagnostic criteria for all components of the lipid profile should be introduced. These are the updated guidelines of the two main scientific societies in Poland in the area - the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA), which, in comparison to those from 2020, introduce few important changes in recommendations (two main lipid targets, new recommendations on LDL-C measurement, new goals for triglycerides, new recommendations on remnants and sdLDL) that should help the practitioners to be early with the lipid disorders diagnosis and monitoring (after therapy initiation), and in the consequence to avoid the first and recurrent cardiovascular events.

Publisher

Termedia Sp. z.o.o.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3